BLTE
Belite Bio Inc

223
Loading...
Loading...
Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
25

Frequently Asked Questions

What is Market Cap of Belite Bio Inc - ADR?
What is the 52-week high for Belite Bio Inc - ADR?
What is the 52-week low for Belite Bio Inc - ADR?
What is Belite Bio Inc - ADR stock price today?
What was Belite Bio Inc - ADR stock price yesterday?
What is the PE ratio of Belite Bio Inc - ADR?
What is the Price-to-Book ratio of Belite Bio Inc - ADR?
What is the 50-day moving average of Belite Bio Inc - ADR?
How many employess does Belite Bio Inc - ADR has?

Latest BLTE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.